Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
暂无分享,去创建一个
H. Hatabu | K. Kuma | K. Kasagi | T. Misaki | Y. Iida | K. Ikekubo | H. Tamai | A. Hidaka | T. Ishihara | T. Morita
[1] H. Kitaoka,et al. DEVELOPMENT OF HYPERTHYROIDISM FOLLOWING PRIMARY HYPOTHYROIDISM: A CASE REPORT WITH CHANGES IN THYROID‐RELATED ANTIBODIES , 1988, Clinical endocrinology.
[2] H. Hatabu,et al. Evaluation of TSH-receptor antibodies as prognostic markers after cessation of antithyroid drug treatment in patients with Graves' disease. , 1988, Acta endocrinologica.
[3] K. Fujieda,et al. TSH-RECEPTOR ANTIBODIES IN MOTHERS WITH GRAVES' DISEASE AND OUTCOME IN THEIR OFFSPRING , 1988, The Lancet.
[4] N. Amino,et al. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. , 1987, The Journal of clinical endocrinology and metabolism.
[5] J. Konishi,et al. A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells. , 1987, Acta endocrinologica.
[6] S. Nagataki,et al. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment. , 1987, The Journal of clinical endocrinology and metabolism.
[7] J. Konishi,et al. Optimization and clinical assessment of a radioreceptor assay for thyrotropin-binding inhibitor immunoglobulins. , 1987, Endocrinologia japonica.
[8] J. Konishi,et al. CHANGES IN THYROID‐STIMULATING AND TSH‐BINDING INHIBITORY ACTIVITIES IN A PATIENT WHO DEVELOPED HYPERTHYROIDISM DUE TO GRAVES' DISEASE FOLLOWING PRIMARY HYPOTHYROIDISM , 1986, Clinical endocrinology.
[9] J. Konishi,et al. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. , 1986, The Journal of clinical endocrinology and metabolism.
[10] D. Pearson,et al. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] J. Konishi,et al. Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients. , 1985, Annals of Internal Medicine.
[12] B. Smith,et al. A RECEPTOR ASSAY FOR THE MEASUREMENT OF TSH RECEPTOR ANTIBODIES IN UNEXTRACTED SERUM , 1984, Clinical endocrinology.
[13] S. Filetti,et al. Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin. , 1984, The Journal of clinical endocrinology and metabolism.
[14] J. Mckenzie,et al. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. , 1983, The Journal of clinical endocrinology and metabolism.
[15] B. Rapoport,et al. Studies on the cyclic AMP response to thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH) in human thyroid cell monolayers. , 1982, Metabolism: clinical and experimental.
[16] J. Konishi,et al. A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase. , 1982, The Journal of clinical endocrinology and metabolism.
[17] J. Mckenzie,et al. Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. , 1980, Annals of internal medicine.
[18] C. Teng,et al. Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. , 1980, The Journal of clinical endocrinology and metabolism.
[19] R. Volpe,et al. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. , 1978, The Journal of clinical endocrinology and metabolism.
[20] S C Werner,et al. Classification of the eye changes of Graves' disease. , 1969, American journal of ophthalmology.